MAPT and depressive disorder: Studies indicate that early-life depression is associated with a 2–4-fold increased risk of developing Alzheimer’s disease (AD) (2, 3), the main feature of which is the aggregation of neurofibrillary tangles (NFTs) after Tau hyperphosphorylation, which is one of the main pathological characteristics of AD (4).